Tutorial
Robinhood Chain
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Alerts on Telegram
Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Data sources
SEC Form 4
4h ago
House PTR
4h ago
SEC 13F
4h ago
Robinhood Chain
4h ago
aTYR PHARMA INC (ATYR) · INSIDER
Public company
aTYR PHARMA INC
ATYR
CIK 0001339970
EDGAR filings
Open in network
○
Watch ATYR
Price
$6.96
1 year
-78.0%
Disclosed transactions
1
Buys / sells
0 / 0
Max Insider Score
9
Connections with evidence
3
Customize layout
ATYR · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
9
YB
Yaras Brandon
Chief Financial Officer
ATYR
aTYR PHARMA INC
Grant or award
A
—
410.0K sh
Oct 1, 2026
Oct 1, 2026
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Holds over 5% of
evidence
FEDERATED HERMES, INC.
0% of class · Schedule 13G · Nov 3, 2026
← Insider of
evidence
Yaras Brandon
Chief Financial Officer · Oct 1, 2026
traded Oct 1, 2026
+0d
SEC Form 4
Evidence
Evidence
Close
Disclosed trades
TradingView
Planned sales and 5% stakes
Form 144, 13D and 13G
FH
Federated Hermes, Inc.
Passive holder · crossed on Oct 31, 2026 · 0 shares
0% of class
13G amendment · filed Nov 4, 2026